Skip to main content

advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse

Project description

Enhancing screening in the drug discovery pipeline will boost successful passage through it

Drug approval still takes about 14 years and the failure rate during clinical trials is about 85 %. At each phase, many targets fail due to safety and efficacy issues, in large part because research models of disease do not adequately model all human factors. SINERGIA will focus on optimising the use of four cutting-edge technologies that support in vivo modelling of drug mechanisms and effects. It brings together academic research entities, contract research organisations, and biotech and pharmaceutical companies. Implementation of better disease models in the drug discovery pipeline could significantly enhance the success and speed at which new candidates are brought from the bench to the bedside.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/medical biotechnology/cells technologies/stem cells
  • /medical and health sciences/medical biotechnology/tissue engineering
  • /engineering and technology/environmental biotechnology/bioremediation/bioreactor
  • /medical and health sciences/basic medicine/physiology

Call for proposal

H2020-MSCA-ITN-2019
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

POLITECNICO DI MILANO
Address
Piazza Leonardo Da Vinci 32
20133 Milano
Italy
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 522 999,36

Participants (9)

UNIVERSITAT BASEL
Switzerland
EU contribution
€ 562 553,28
Address
Petersplatz 1
4051 Basel
Activity type
Higher or Secondary Education Establishments
UNIVERSITEIT MAASTRICHT
Netherlands
EU contribution
€ 531 239,76
Address
Minderbroedersberg 4-6
6200 MD Maastricht
Activity type
Higher or Secondary Education Establishments
FAKULTNI NEMOCNICE U SV. ANNY V BRNE
Czechia
EU contribution
€ 469 743,12
Address
Pekarska 53
656 91 Brno
Activity type
Higher or Secondary Education Establishments
UNIVERSITAETSKLINIKUM AACHEN
Germany
EU contribution
€ 252 788,40
Address
Pauwelsstrasse 30
52074 Aachen
Activity type
Higher or Secondary Education Establishments
Ente Ospedaliero Cantonale
Switzerland
EU contribution
€ 562 553,28
Address
Vialle Officina 3
CH-6500 Bellinzona
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
ACCELERA SRL
Italy
EU contribution
€ 261 499,68
Address
Viale Pasteur 10
20014 Nerviano Mi
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LIFETEC GROUP BV
Netherlands
EU contribution
€ 265 619,88
Address
Kennedyplein 11
5611 ZS Eindhoven
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
BIOMIMX SRL
Italy
EU contribution
€ 261 499,68
Address
Via Giovanni Durando 38/A
20158 Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MTTLAB SRL
Italy
EU contribution
€ 261 499,68
Address
Via Giacinto Gallina 5
34132 Trieste
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)